These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29546814)

  • 21. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
    Omland T; Aakvaag A; Vik-Mo H
    Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of preoperative N-terminal pro-brain natriuretic peptide in non-cardiac surgery of elderly patients with normal left ventricular systolic function.
    Kim IJ; Moon JY; Ko EJ; Lim YM; Kim SH; Yang WI; Sung JH; Lim SW; Cha DH
    Geriatr Gerontol Int; 2016 Oct; 16(10):1109-1116. PubMed ID: 26336935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does N-terminal pro-brain natriuretic peptide correlate with measured shunt fraction in children with septal defects?
    Ozyurt A; Baykan A; Argun M; Pamukcu O; Uzum K; Narin F; Narin N
    Cardiol Young; 2016 Mar; 26(3):469-76. PubMed ID: 25858635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy.
    Garcia S; Akbar MS; Ali SS; Kamdar F; Tsai MY; Duprez DA
    Int J Cardiol; 2010 Sep; 143(3):349-52. PubMed ID: 19356808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of NT-ProBNP for left ventricular hypertrophy in hemodialysis patients.
    Maoujoud O; Asseraji M; Aatif T; Zajjari Y; Bahadi A; Benyahya M; Tellal S
    Int J Artif Organs; 2013 Jun; 36(6):419-20. PubMed ID: 23653297
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women.
    Mouly-Bertin C; Bissery A; Milon H; Dzudie A; Rabilloud M; Bricca G; Vincent M; Lantelme P
    Arch Cardiovasc Dis; 2008 May; 101(5):307-15. PubMed ID: 18656089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mitofilin in left ventricular hypertrophy in hemodialysis patients.
    Wu QS; He Q; He JQ; Chao J; Wang WY; Zhou Y; Lou JZ; Kong W; Chen JF
    Ren Fail; 2018 Nov; 40(1):252-258. PubMed ID: 29619900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.
    Fahim MA; Hayen A; Horvath AR; Dimeski G; Coburn A; Johnson DW; Hawley CM; Campbell SB; Craig JC
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):620-9. PubMed ID: 25714960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease.
    Coats CJ; Parisi V; Ramos M; Janagarajan K; O'Mahony C; Dawnay A; Lachmann RH; Murphy E; Mehta A; Hughes D; Elliott PM
    Am J Cardiol; 2013 Jan; 111(1):111-7. PubMed ID: 23040658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma concentrations of N-terminal pro-brain natriuretic peptide reflect the presence of mildly reduced left ventricular diastolic function in hypertension.
    Furumoto T; Fujii S; Mikami T; Inoue M; Nishihara K; Kaga S; Imagawa S; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Sobel BE
    Coron Artery Dis; 2006 Feb; 17(1):45-50. PubMed ID: 16374141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.